List of Cetylev drug patents

Cetylev is owned by Arbor Pharms Llc.

Cetylev contains Acetylcysteine.

Cetylev has a total of 3 drug patents out of which 0 drug patents have expired.

Cetylev was authorised for market use on 29 January, 2016.

Cetylev is available in tablet, effervescent;oral dosage forms.

Cetylev can be used as method of treating acetaminophen overdose with acetylcysteine solutions.

The generics of Cetylev are possible to be released after 08 May, 2032.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8747894 ARBOR PHARMS LLC Effervescent compositions containing N-acetylcysteine
May, 2032

(9 years from now)

US9561204 ARBOR PHARMS LLC Effervescent compositions containing N-acetylcysteine
May, 2032

(9 years from now)

US9427421 ARBOR PHARMS LLC Effervescent compositions containing N-acetylcysteine
May, 2032

(9 years from now)

Drugs and Companies using ACETYLCYSTEINE ingredient

Market Authorisation Date: 29 January, 2016

Treatment: Method of treating acetaminophen overdose with acetylcysteine solutions

Dosage: TABLET, EFFERVESCENT;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic